Your browser doesn't support javascript.
loading
Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines.
Giudice, Stefania; Benassi, Luisa; Bertazzoni, Giorgia; Veratti, Eugenia; Morini, Daria; Azzoni, Paola; Costi, Maria P; Venturelli, Alberto; Pirondi, Silvia; Seidenari, Stefania; Magnoni, Cristina.
Affiliation
  • Giudice S; Department of Dermatology, University of Modena and Reggio Emilia, Via del Pozzo, 71-41126 Modena, Italy.
Invest New Drugs ; 30(4): 1484-92, 2012 Aug.
Article in En | MEDLINE | ID: mdl-21881917

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyglutamic Acid / Thymidylate Synthase / Cell Cycle / Coumarins / Enzyme Inhibitors / Folic Acid Antagonists / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Invest New Drugs Year: 2012 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyglutamic Acid / Thymidylate Synthase / Cell Cycle / Coumarins / Enzyme Inhibitors / Folic Acid Antagonists / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Invest New Drugs Year: 2012 Type: Article Affiliation country: Italy